These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
296 related items for PubMed ID: 23364194
1. Arenavirus reverse genetics for vaccine development. Ortiz-Riaño E, Cheng BYH, Carlos de la Torre J, Martínez-Sobrido L. J Gen Virol; 2013 Jun; 94(Pt 6):1175-1188. PubMed ID: 23364194 [Abstract] [Full Text] [Related]
2. Development of live-attenuated arenavirus vaccines based on codon deoptimization. Cheng BY, Ortiz-Riaño E, Nogales A, de la Torre JC, Martínez-Sobrido L. J Virol; 2015 Apr; 89(7):3523-33. PubMed ID: 25589652 [Abstract] [Full Text] [Related]
3. Generation of recombinant arenavirus for vaccine development in FDA-approved Vero cells. Cheng BY, Ortiz-Riaño E, de la Torre JC, Martínez-Sobrido L. J Vis Exp; 2013 Aug 01; (78):. PubMed ID: 23928556 [Abstract] [Full Text] [Related]
4. Reverse Genetics Approaches to Control Arenavirus. Martínez-Sobrido L, Cheng BY, de la Torre JC. Methods Mol Biol; 2016 Aug 01; 1403():313-51. PubMed ID: 27076139 [Abstract] [Full Text] [Related]
5. Arenavirus Genome Rearrangement for the Development of Live Attenuated Vaccines. Cheng BY, Ortiz-Riaño E, de la Torre JC, Martínez-Sobrido L. J Virol; 2015 Jul 01; 89(14):7373-84. PubMed ID: 25972555 [Abstract] [Full Text] [Related]
6. Novel strategies for development of hemorrhagic fever arenavirus live-attenuated vaccines. Martinez-Sobrido L, de la Torre JC. Expert Rev Vaccines; 2016 Sep 01; 15(9):1113-21. PubMed ID: 27118328 [Abstract] [Full Text] [Related]
7. Reverse genetics approaches to combat pathogenic arenaviruses. de la Torre JC. Antiviral Res; 2008 Dec 01; 80(3):239-50. PubMed ID: 18782590 [Abstract] [Full Text] [Related]
8. Development of live-attenuated arenavirus vaccines based on codon deoptimization of the viral glycoprotein. Cheng BYH, Nogales A, de la Torre JC, Martínez-Sobrido L. Virology; 2017 Jan 15; 501():35-46. PubMed ID: 27855284 [Abstract] [Full Text] [Related]
9. Identification and Mechanism of Action of a Novel Small-Molecule Inhibitor of Arenavirus Multiplication. Ngo N, Henthorn KS, Cisneros MI, Cubitt B, Iwasaki M, de la Torre JC, Lama J. J Virol; 2015 Nov 15; 89(21):10924-33. PubMed ID: 26292327 [Abstract] [Full Text] [Related]
10. Development of Reverse Genetics for the Prototype New World Mammarenavirus Tacaribe Virus. Ye C, de la Torre JC, Martínez-Sobrido L. J Virol; 2020 Sep 15; 94(19):. PubMed ID: 32669332 [Abstract] [Full Text] [Related]
11. Rescue from cloned cDNAs and in vivo characterization of recombinant pathogenic Romero and live-attenuated Candid #1 strains of Junin virus, the causative agent of Argentine hemorrhagic fever disease. Emonet SF, Seregin AV, Yun NE, Poussard AL, Walker AG, de la Torre JC, Paessler S. J Virol; 2011 Feb 15; 85(4):1473-83. PubMed ID: 21123388 [Abstract] [Full Text] [Related]
12. Generation of Bi-Reporter-Expressing Tri-Segmented Arenavirus. Ye C, Martinez-Sobrido L. Methods Mol Biol; 2022 Feb 15; 2524():223-233. PubMed ID: 35821475 [Abstract] [Full Text] [Related]
13. Development of Recombinant Arenavirus-Based Vaccines. Martínez-Sobrido L, de la Torre JC. Methods Mol Biol; 2017 Feb 15; 1581():133-149. PubMed ID: 28374247 [Abstract] [Full Text] [Related]
16. Inhibition of arenavirus by A3, a pyrimidine biosynthesis inhibitor. Ortiz-Riaño E, Ngo N, Devito S, Eggink D, Munger J, Shaw ML, de la Torre JC, Martínez-Sobrido L. J Virol; 2014 Jan 15; 88(2):878-89. PubMed ID: 24198417 [Abstract] [Full Text] [Related]